-
(131-17) A Phase 1/2 Safety Study of Intratumorally Administered INT230-6
in Adult Subjects with Advanced Refractory Cancers (Phase 1 clinical trial, appropriate for patients with solid tumors.)
-
(152-17) A Modular Phase I, Open-Label, Multicentre Study to Assess Ascending
Doses of AZD6738 in Combination With Chemotherapy and/or Novel Anti Cancer Agents (Phase 1 clinical trial, appropriate for patients with advanced solid
malignancies of the breast.)
-
(155-17) 0C 17-1: Phase 1 Multi-center Study of the Safety Pharmacokinetics
and Preliminary Efficacy of CBT-101 in Subjects with Advanced Solid Tumors
and C-Met Dysregulation (Phase 1 clinical trial, appropriate for patients with advanced solid
malignancies.)
-
(187-17) Phase 1 trial of ZW25 in patients with locally advanced (unresectable)
and/or metastatic HER2-expressing cancers (Phase 1 clinical trial, appropriate for patients with HER2 expressing cancers.)
-
(211-17) An Open-Label, Non-Randomized, Multicenter Study to Determine
the Pharmacokinetics and Safety of Niraparib Following A Single Oral Dose
in Patients with Advanced Solid Tumors and Either Normal Hepatic Function
or Moderate Hepatic Impairment (Phase 1 clinical trial, appropriate for patients with advanced solid tumors.)
-
(214-17) A Phase 1/2 First-in-human Study of BMS-986258 Alone and in Combination
with Nivolumab in Advanced Malignant Tumors (Phase 1/2 clinical trial, appropriate for patients with advanced malignant tumors.)